Codexis to Report First Quarter 2023 Financial Results on May 4
April 20 2023 - 4:05PM
Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,
today announced that it will report its financial results for the
first quarter of 2023 on Thursday, May 4, 2023, following the close
of market. The Company will not be conducting a conference call in
conjunction with this financial results release.
About Codexis
Codexis is a leading enzyme engineering company leveraging its
proprietary CodeEvolver® technology platform to discover, develop
and enhance novel, high performance enzymes and other classes of
proteins. Codexis enzymes solve for real-world challenges
associated with small molecule pharmaceuticals manufacturing,
nucleic acid synthesis and genomic sequencing, and – as
biotherapeutic candidates – they have the potential to treat
challenging diseases. Codexis’ unique enzymes drive improvements
such as higher yields, reduced energy usage and waste generation,
improved efficiency in manufacturing, greater sensitivity in
genomic and diagnostic applications and potentially more
efficacious therapeutics. For more information,
visit www.codexis.com.
For More Information
Investor ContactCarrie McKim(336) 608-9706ir@codexis.com
Media ContactLauren Musto(781) 572-1147media@codexis.com
Codexis (NASDAQ:CDXS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Codexis (NASDAQ:CDXS)
Historical Stock Chart
From Jul 2023 to Jul 2024
